P115 A phase 2 multicenter study of the investigational single agent orteronel (ortl, TAK-700) in nonmetastatic castration-resistant prostate cancer (nmCRPC) and rising prostate-specific antigen (PSA)

✍ Scribed by Hussain, M.; Corn, P.G.; Michaelson, D.; Hammers, H.J.; Alumkal, J.J.; Ryan, C.J.; Bruce, J.Y.; Moran, S.; Lee, S.Y.; Mortimer, P.; George, D.J.

• Book ID: 122677293
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 75 KB
• Volume: 11
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(13)60481-9